Approval · Notice of Compliance 4798 · 2004
PROSCAR: Notice of Compliance 4798
Issued July 15, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4798
- Date
- July 15, 2004
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New administration: medical therapy of prostate symptoms (mtops). combinaison of proscar and doxazosin to reduce the risk of symptomatic progression of bph
- Therapeutic class
- Type II 5 alpha-reductase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROSCAR | Not yet assigned | — |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB